title: Apolipoprotein L1-associated nephropathy and the future of renal diagnostics.
authors.affiliation: Nephropath, Little Rock, Arkansas; and chris.larsen@nephropath.com.
authors.forename: Christopher P
authors.initials: CP
authors.lastname: Larsen
authors.affiliation: Department of Internal Medicine, Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, North Carolina.
authors.forename: Barry I
authors.initials: BI
authors.lastname: Freedman
mesh_terms: D001053:Apolipoproteins / Q000235:genetics*; D003524:Cyclosporins / Q000627:therapeutic use*; D003907:Dexamethasone / Q000627:therapeutic use*; D005260:Female; D005923:Glomerulosclerosis, Focal Segmental / Q000188:drug therapy* / Q000235:genetics*; D006801:Humans; D008075:Lipoproteins, HDL / Q000235:genetics*; D008297:Male; D009173:Mycophenolic Acid / Q000031:analogs & derivatives*
chemical_list: D001053:Apolipoproteins; D003524:Cyclosporins; D008075:Lipoproteins, HDL; D003907:Dexamethasone; D009173:Mycophenolic Acid
keywords: APOL1; FSGS; HIV nephropathy; collapsing FSGS; collapsing glomerulopathy; genetic; idiopathic nephrotic syndrome; renal disease